Introduction: Previous reports have shown that suboptimal antenatal corticosteroids
corticosteroids and delivered between 24
0/7 and 34 6/7 weeks of gestation during 2015-2017 at 2 university hospitals. Optimal antenatal corticosteroids timing was defined as delivery ≥24 hours ≤7 days from the previous antenatal corticosteroids course.
Results: Of 424 pregnancies, 307 (72.4%) were singleton and 117 were (27.6%) twin.
For twin compared with singleton pregnancies, gestational age at initial antenatal corticosteroids administration was lower (P = 0.02), the proportion of deliveries within the optimal window of the initial antenatal corticosteroids course was lower (19.7% vs 33.2%, P = 0.001), and the proportion of women eligible for a rescue antenatal corticosteroids course was higher (58.1% vs 32.9%, P < 0.0001). However, despite similar rates of rescue antenatal corticosteroids administration (P = 0.64), the overall rate of delivery within any optimal window (either initial or rescue course) was lower in twin than singleton pregnancies (26.5% vs 42.3%, P = 0.004), and the antenatal corticosteroids-to-delivery interval was longer (median 6.9 vs 4.2 days, P = 0.0009). In multivariate analysis, optimal antenatal corticosteroids administration was negatively associated with twin pregnancy (P = 0.04) and preterm labor (P = 0.05), and positively associated with the presence of gestational hypertensive disorders (P = 0.03).
Conclusions:
Twin pregnancy is an independent risk factor for suboptimal antenatal corticosteroids administration. Directed efforts should be made to improve the utilization of antenatal corticosteroids in this vulnerable group of women.
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| INTRODUC TI ON
Preterm birth is the leading cause of perinatal morbidity and mortality worldwide. 1, 2 The incidence of twin pregnancies has dramatically increased over the last decades, due to the widespread use of assisted reproductive technologies and increased maternal age. 3 As almost 60% of twins are born prematurely (<37 weeks of gestation) and up to 14.5% are born before 34 weeks of gestation, accounting for more than 20% of all preterm births, twins are at particularly high risk for prematurity-related complications. 4, 5 The landmark study by Liggins and Howie 6 demonstrated that the timing of antenatal corticosteroids (ACS) administration to women at risk of preterm delivery has a major effect on its likelihood of benefit; their findings were supported by later studies. [7] [8] [9] The favorable effects of ACS have been perceived to be weaker among twin pregnancies. [10] [11] [12] Nonetheless, optimal timing of ACS administration, at 1-7 days before birth, was found to be associated with a significant decrease in neonatal mortality and morbidity in twin pregnancies; the magnitude of which was similar to that observed among singletons. 13 As timely administration of ACS is critical to ensure its benefit, several studies have investigated the factors associated with optimal ACS timing. These reports have shown that suboptimal ACS administration occurs in most cases. However, as multifetal gestations were either excluded or constituted a small proportion of the participants in these studies, [14] [15] [16] [17] little is known about the patterns of use of ACS in twin pregnancies. The aim of this study was to characterize the use and optimal timing of ACS among twin vs singleton pregnancies.
| MATERIAL AND ME THODS
This is a retrospective cohort study. Our center is a tertiary care referral center with over 10 000 deliveries per year. In addition, a multivariable logistic regression analysis was performed to assess factors independently associated with optimal ACS administration. A 2-sided P-value <0.05 indicated statistical significance.
| Statistical analyses
The data were analyzed using Software Package for Statistics and Simulation (IBM SPSS version 22, IBM Corp, Armonk, NY).
| Ethical approval
The study was approved in January 2018 by the Human Investigation
Review Board of Hadassah-Hebrew University Medical center (IRB approval number: HMO-0156-18).
| RE SULTS
A total of 26 478 women delivered at our center during the study period. Overall, 604 (2.3%) women with twin or singleton pregnancies delivered between 24 0/7 and 34 6/7 weeks of gestation. Of them, 424
(70.2%) women, 307 (72.4%) with singleton and 117 (27.6%) with twin pregnancies, received at least 1 dose of ACS before delivery.
Among the 117 twin pregnancies, most were dichorionic diamniotic (n = 73), followed by monochorionic diamniotic (n = 40), and monochorionic monoamniotic (n = 4).
Demographic and baseline clinical characteristics, and obstetric history were similar between those with twin and singleton pregnancies (Table 1) . Indications for ACS administration varied significantly according to plurality (P = 0.008), with higher proportions of women with symptomatic preterm labor, asymptomatic cervical changes, and fetal indications, and lower proportions of ACS administration due to vaginal bleeding, hypertensive disorders, and preterm premature rupture of membranes among those with twin compared with singleton pregnancies ( Table 2 ). The indications for ACS administration did not differ according to the GA at delivery (see Supplementary material, Table S1 ).
Women with twin pregnancies were more likely to receive the initial ACS course at an earlier GA than were those with singleton pregnancies (median 29 vs 30 weeks, P = 0.02). The median initial ACS course-to-delivery interval was longer in those with twin than singleton pregnancies (16.9 vs 6.0 days, P < 0.0001). Considering only the initial ACS course, the rate of optimal timing (ACS-to-delivery interval ≥24 hours and ≤7 days) was significantly lower in twin compared with singleton pregnancies (19.7% vs 33.2%, P = 0.001) (Table 2) . Similarly, when optimal timing was considered as initial ACS course-to-delivery interval ≥48 hours and ≤7 days, its rate was decreased in twin compared with singleton pregnancies (14.5% vs 28.0%, P = 0.001). In addition, the rate of delivery within the optimal ACS window following the initial ACS course, was similar in those with twin and singleton pregnancies among those who delivered between 24 0/7 and 28 6/7 (50.0% vs 42.6%, P = 0.89), whereas among those who delivered at later GA, the rate of optimal timing was significantly lower in twin compared with singleton pregnancies (15.5% vs 31.2%, P = 0.001) (see Supplementary material, Table S1 ).
The proportion of women eligible for a rescue ACS course was higher among those with twin than singleton pregnancies (58.1% vs 32.9%, P < 0.0001). Of those eligible in the entire cohort, 86 (50.9%) received a rescue ACS course; the rate was comparable among those with twin and singleton pregnancies (48.5% vs 52.5%, P = 0.64). The median GA at the time of rescue ACS administration (30 vs 31 weeks, P = 0.32) and the time lapsed from the initial ACS course (26 vs 26 days, P = 0.79) were similar among those with twin vs singleton pregnancies. Considering only the rescue ACS course, the rate of optimal timing was decreased in twin compared with singleton pregnancies (24.2% vs 52.8%, P = 0.03). Similarly, when optimal timing was considered as rescue ACS course-to-delivery interval ≥48 hours and ≤7 days, its rate was significantly lower in twin compared with singleton pregnancies (15.2% vs 43.4%, P = 0.02).
The rate of delivery within any optimal ACS window (either initial or rescue course) was significantly lower among twin than singleton pregnancies (26.5% vs 42.3%, P = 0.004) ( Table 2) . Gestational age at delivery and the proportion of medically indicated preterm births were comparable between twin and singleton pregnancies (P = 0.38 and P = 0.27, respectively) ( Table 2 ). The rate of delivery within any optimal ACS window was comparable between dichorionic diamniotic and monochorionic diamniotic twin pregnancies (27.4% vs 22.5%, P = 0.66). When optimal timing was considered as ACS course-to-delivery interval ≥48 hours and ≤7 days, the rate of delivery within any optimal ACS window (either initial or rescue course) was decreased among twin compared with singleton pregnancies (18.8% vs 35.5%, P = 0.001).
In univariate analysis, indication for ACS administration, presence of gestational hypertensive disorders, and gestation plurality (singleton vs twins) were found to correlate with optimal ACS timing ( Table 3) . In multivariate analysis, optimal ACS timing was negatively associated with twin pregnancy (odds ratio 0.59, 95% CI 0.37-0.96), P = 0.04) and symptomatic preterm labor (odds ratio 0.74, 95% CI 0.36-0.99, P = 0.05), and positively associated with gestational hypertensive disorder (odds ratio 1.8, 95% CI 1.03-3.45, P = 0.03).
| D ISCUSS I ON
In this retrospective study, twin pregnancy was an independent risk factor for suboptimal ACS administration compared with singleton pregnancy; nearly 75% of women with twins delivered outside the optimal window for either the initial or rescue ACS courses. In addition, optimal ACS administration was negatively associated with symptomatic preterm labor and positively associated with the presence of gestational hypertensive disorders.
Whether the beneficial effects of ACS are similar among twin and singleton pregnancies has been questioned. Concerns have been raised by several studies that demonstrated diminished improvement in neonatal outcomes following ACS administration in twin compared with singleton pregnancies. [10] [11] [12] However, the aforementioned studies [10] [11] [12] included relatively small numbers of twins and the time interval from ACS administration was not controlled, thereby limiting the interpretation that can be derived. Finally, a recent well-designed retrospective study showed that optimal ACS administration The denominator is the total number of patients eligible for rescue ACS course; eg did not deliver following 14 days from the first ACS course. d The denominator is the number of patients who received a rescue ACS course. e Calculated as the time interval from the first dose of the last ACS course administered until delivery.
TA B L E 2 Characteristics of antenatal corticosteroids (ACS) administration and related outcomes among twin and singleton pregnancies
led to similar improvement in outcomes between singleton and twin neonates. 13 Our overall optimal ACS administration rate was 38%, which is similar to that reported by previous publications. 7, 16 We have shown that twin pregnancy represented an independent risk factor for suboptimal ACS administration due to early ACS administration (ACSto-delivery interval >7 days) compared with singleton pregnancy.
This important finding may be accounted for by several factors.
First, although the challenging prediction of preterm birth has significantly improved in the last 2 decades among singleton pregnancies, less progress has been achieved among twin gestations. This limits our ability to optimize ACS administration within a narrow timeframe in this subset of women. 5 Second, in their eagerness and haste, healthcare providers may treat women with twin pregnancies too early, as reflected by the lower GA at the administration of the first ACS course, as well as the longer ACS-to-delivery interval found in our cohort.
Despite similar rates of rescue ACS administration, the overall optimal ACS administration rate (ie including those who received a rescue course) was significantly lower in twin than singleton pregnancies. This further highlights the complexity of prediction of delivery timing and the fact that we cannot rely on the rescue course as an ultimate lifeline. This conclusion concurs with a recent study that showed that implementation of a rescue ACS protocol did not TA B L E 3 Factors related to optimal antenatal corticosteroids (ACS) administration lead to improved ACS timing. 19 Moreover, as a higher proportion of women with twin pregnancies remained undelivered 1 week following the initial ACS administration, the proportion of those eligible for a rescue ACS course was higher than among singleton pregnancies. This is potentially worrisome as the use of repeated ACS courses was previously found to associate with decreased birthweight and head circumference. 20, 21 In addition, the efficacy and safety of rescue ACS in twin pregnancies is still debated.
Finally, rescue course timing in relation to the initial course is not established-with some supporting its administration as early as 7 days from the previous dose if indicated by the clinical scenario, while others recommend a minimum of 2 weeks interval from the antecedent ACS course. 18 This further emphasizes the need to target the initial ACS course more appropriately and avoid its administration altogether in those expected to be at low risk for delivery within 7 days.
We report that symptomatic preterm labor was associated with suboptimal timing, whereas the presence of gestational hypertensive disorders increased the likelihood of optimal ACS administration.
These findings are in accordance with previous reports. 13, 14, 16, 17, 19 The higher rate of optimal timing among those with hypertensive disorders probably results from the ability to dictate delivery timing, as most preterm births are indicated in this scenario. 16 However, despite the higher accuracy of ACS timing observed among those with hypertensive disorders in our cohort, a substantial portion (41.7%) of them had suboptimal timing. This highlights the poor predictability of delivery timing even in this subset of women.
Several collaborative have been issued with the aim of optimizing appropriate and timely ACS administration. 18 Although it was once held that ACS should be provided routinely in certain clinical scenarios in a "treat-all" manner, it is now clear that a change in clinical practice towards a selective approach among those with certain high-risk characteristics for preterm birth is more suitable. 15, 22, 23 The implementation of predictive tools of preterm labor and laboratory biomarkers, and appropriate monitoring and documentation of ACS use have been proposed as strategies to guide targeted ACS therapy and to improve accuracy. 18, 22, 24 Further studies assessing these strategies should specifically be carried among women with multifetal gestations as according to the current study findings, plurality of gestation should be taken into account in women's risk stratification for preterm birth. Given the rising twin birth rate, avoiding overuse of ACS among low-risk women with twin pregnancies is critical, not only to withhold unnecessary treatment but also to prevent harm. 23 Improving our utilization of ACS in these particularly vulnerable preterm infants is expected to translate into meaningful improvement in shortterm and long-term outcomes.
The retrospective design of this study raises the possibility of biases inherent to such investigations. Another limitation is the lack of a systematic approach regarding ACS administration among individual physicians; however, this may have affected the timing of ACS. In addition, the conduct of the study in a single institution may limit the generalizability of the results to different populations. Moreover, the current study was not designed to assess the effect of ACS on neonatal outcomes; however, as discussed, others have shown a comparable effect in twin and singleton neonates when ACS were optimally timed. 13 Finally, the study group included women who delivered before 34 weeks of gestation, as the benefit of ACS is well-established in this subset of women. We did not include women who went on to deliver after 34 weeks of gestation; including those women would have likely contributed to a longer ACS-to-delivery interval and an even lower rate of optimal ACS administration in the twin pregnancy group. On the other hand, the main strengths of our study include its relatively large cohort of women and meticulous data collection, including information on important confounding risk factors.
| CON CLUS ION
In the current cohort, twin pregnancy independently increased the likelihood of suboptimal ACS timing. This may negatively affect neonatal outcomes, as accurate timing of ACS course is crucial for the attainment of its attributed benefits. Future studies are warranted to confirm our findings and optimize the administration of ACS in twins, for improvement in their short-term and long-term outcomes.
